
Bharat Immunological & Biological Corporation Ltd is Rated Strong Sell
2026-10-23 10:10:33Bharat Immunological & Biological Corporation Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 09 April 2024. However, the analysis and financial metrics discussed below reflect the company’s current position as of 23 October 2026, providing investors with an up-to-date perspective on the stock’s fundamentals, valuation, financial trend, and technical outlook.
Read More
Bharat Immunological & Biological Corporation Ltd Falls to 52-Week Low of Rs 9.05 as Sell-Off Deepens
2026-09-30 09:47:08For the sixth consecutive session, Bharat Immunological & Biological Corporation Ltd has closed lower, culminating in a fresh 52-week low of Rs 9.05 on 30 Sep 2026. This marks a steep 33.79% decline over this losing streak, underscoring persistent selling pressure despite a modestly recovering Sensex.
Read More
Bharat Immunological & Biological Corporation Ltd is Rated Strong Sell
2026-09-29 10:10:40Bharat Immunological & Biological Corporation Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 09 Apr 2024. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 29 September 2026, providing investors with an up-to-date view of the company’s performance and outlook.
Read More
Bharat Immunological & Biological Corporation Ltd Falls to 52-Week Low of Rs 13.02 as Sell-Off Deepens
2026-09-24 09:48:34A sharp decline has pushed Bharat Immunological & Biological Corporation Ltd to a fresh 52-week low of Rs 13.02 on 24 Sep 2026, marking a continuation of recent losses amid a challenging market environment and company-specific headwinds.
Read More
Bharat Immunological & Biological Corporation Ltd Falls to 52-Week Low of Rs 13.3 as Sell-Off Deepens
2026-09-23 13:06:03For the fifth consecutive session, Bharat Immunological & Biological Corporation Ltd closed lower, slipping to a fresh 52-week low of Rs 13.3 on 23 Sep 2026, marking a 38.17% decline over the past year amid persistent underperformance and deteriorating fundamentals.
Read More
Bharat Immunological & Biological Corporation Ltd Falls to 52-Week Low of Rs 13.96 as Sell-Off Deepens
2026-09-21 13:06:50For the third consecutive session, Bharat Immunological & Biological Corporation Ltd has seen its share price decline, culminating in a fresh 52-week low of Rs 13.96 on 21 Sep 2026. This marks a significant 38.2% drop from its 52-week high of Rs 22.61, underscoring persistent selling pressure despite a broadly positive market backdrop.
Read More
Bharat Immunological & Biological Corporation Ltd Falls to 52-Week Low of Rs 14.06 as Sell-Off Deepens
2026-09-18 10:13:06A sharp decline in Bharat Immunological & Biological Corporation Ltd shares has pushed the stock to a fresh 52-week low of Rs 14.06 on 18 Sep 2026, marking a 7.21% drop over the past two sessions amid continued underperformance relative to its sector and benchmark indices.
Read More
Bharat Immunological & Biological Corporation Ltd is Rated Strong Sell
2026-09-17 10:10:56Bharat Immunological & Biological Corporation Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 09 April 2024. However, the analysis and financial metrics discussed here reflect the stock's current position as of 17 September 2026, providing investors with an up-to-date view of the company’s performance and outlook.
Read MoreClarification sought from Bharat Immunologicals & Biologicals Corporation Ltd
30-Sep-2026 | Source : BSEThe Exchange has sought clarification from Bharat Immunologicals & Biologicals Corporation Ltd on September 30 2026 with reference to significant movement in price in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.
The reply is awaited.
Announcement under Regulation 30 (LODR)-Winding-up
17-Sep-2026 | Source : BSEPursuant to the Regulation 30 and other applicable Regulation(s) of SEBI LODR It is informed that the Government of India has approved the closure of Bharat Immunologicals and Biologicals Corporation Limited (BIBCOL) under Administrative control of Department of Biotechnology Ministry of Science & Technology Government of India. This information is being submitted with reference to the communication received on 17.09.2026 from Department of Biotechnology.
Board Meeting Intimation for Intimation Of Date Of Board Meeting On 16.08.2024 Under Regulation 29 Of SEBIS LODR.
07-Aug-2024 | Source : BSEBHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/08/2024 inter alia to consider and approve Pursuant to the Regulation 29 and other applicable Regulation(s) of Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations 2015 it is informed that a meeting of the Board of Directors of the Company is scheduled to be held on Friday 16th August 2024 for General Purpose.
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
